CLINICAL_TRIALS
trial_result
· 2011-12-01
Clinical Trial Update: A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients [Phase 3]
Summary
A Phase 3 safety and efficacy study of sitaxentan sodium in Japanese patients with pulmonary arterial hypertension was terminated; trial results were posted in …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Hypertension, Pulmonary | Phase 3 | Status: TERMINATED | Results posted: 2011-12-01